U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8427184271Levetiracetam to Prevent Post-Traumatic EpilepsyCompletedNo Results AvailableEpilepsy|Post-traumatic EpilepsyDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT01463033
8427284272Behavioural Activation-Based Treatment Administered Through SmartphoneCompletedNo Results AvailableDepressionBehavioral: Smartphone delivered BA|Other: Smartphone delivered mindfulnesshttps://ClinicalTrials.gov/show/NCT01463020
8427384273Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast CancerActive, not recruitingHas ResultsBreast CancerRadiation: Accelerated partial breast irradiationhttps://ClinicalTrials.gov/show/NCT01463007
8427484274Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)RecruitingNo Results AvailableGastrointestinal Stromal TumorsOther: Blood will be withdrawn at baseline and in intervals of 3 months for a total period of 2 yearshttps://ClinicalTrials.gov/show/NCT01462994
8427584275Cohort of Hepatitis B Research of AmsterdamRecruitingNo Results AvailableHepatitis Bhttps://ClinicalTrials.gov/show/NCT01462981
8427684276Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac SurgeryWithdrawnNo Results AvailableCardiac SurgeryDevice: Activated clotting time versus blood-heparin concentrationhttps://ClinicalTrials.gov/show/NCT01462968
8427784277[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01462955
8427884278Long-term Efficacy and Safety of Aclidinium/Formoterol Fixed-Dose CombinationCompletedNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Drug: Aclidinium Bromide/Formoterol Fumarate|Drug: Aclidinium Bromide/Formoterol Fumarate|Drug: Aclidinium Bromide|Drug: Placebo|Drug: Formoterol Fumaratehttps://ClinicalTrials.gov/show/NCT01462942
8427984279Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsChronic Obstructive Pulmonary Disease (COPD)Drug: Aclidinium bromide|Drug: Tiotropium|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01462929
8428084280Honey in Chronic Immune ThrombocytopeniaSuspendedNo Results AvailableChronic Thrombocytopenic PurpuraDietary Supplement: honeyhttps://ClinicalTrials.gov/show/NCT01462916
8428184281A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsRecruitingNo Results AvailableNasopharyngeal Carcinoma|Hepatocellular Carcinoma|Breast CarcinomaBiological: tumor infiltrating lymphocytes, IL-2https://ClinicalTrials.gov/show/NCT01462903
8428284282Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian CancerActive, not recruitingNo Results AvailableGenital Diseases, Female|Ovarian Diseases|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal NeoplasmsBiological: Bevacizumab|Biological: Bevacizumab|Drug: Paclitaxel|Drug: Carboplatin|Other: specialized pathology review (Germany only)https://ClinicalTrials.gov/show/NCT01462890
8428384283A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With DyslipidemicCompletedHas ResultsDyslipidemias|Cardiovascular Diseases|HypertriglyceridemiaDrug: fenofibratehttps://ClinicalTrials.gov/show/NCT01462877
8428484284Development of a Structured Education Programme for Women With Polycystic Ovary SyndromeRecruitingNo Results AvailablePolycystic Ovary SyndromeBehavioral: Structured Lifestyle Educationhttps://ClinicalTrials.gov/show/NCT01462864
8428584285A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy AdultsCompletedNo Results AvailableHealthyDrug: PF-05297909 25 mg|Drug: PF-05297909 100 mg|Drug: PF-05297909 250 mg|Drug: PF-05297909 525 mg|Drug: PF-05297909 525 mghttps://ClinicalTrials.gov/show/NCT01462851
8428684286Immune Therapy of HPV-induced CancersCompletedNo Results AvailableHPV-induced CancersBiological: P16_37-63https://ClinicalTrials.gov/show/NCT01462838
8428784287The Effect of Tomato Ketchup on InflammationCompletedNo Results AvailableInflammationDietary Supplement: tomato ketchup meal|Dietary Supplement: Placebo mealhttps://ClinicalTrials.gov/show/NCT01462825
8428884288Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute MigraineCompletedHas ResultsMigraine HeadacheDrug: Sumatriptan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01462812
8428984289COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-careRecruitingNo Results AvailableCoronary Heart DiseaseBehavioral: PBL in patient education|Behavioral: Mailed patient informationhttps://ClinicalTrials.gov/show/NCT01462799
8429084290To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101CompletedNo Results AvailableHealthyDrug: ATX-101https://ClinicalTrials.gov/show/NCT01462786
8429184291Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant MelanomaCompletedHas ResultsMelanomaDrug: Bortezomib|Drug: Interferon Alfa-2bhttps://ClinicalTrials.gov/show/NCT01462773
8429284292Contribution of Actigraphy for the Evaluation of Elbow Range of Motion in the Joint Assessment in GerontologyRecruitingNo Results AvailableGeriatric DisorderDevice: Assessment with inclinometer|Device: Assessment with actigraphhttps://ClinicalTrials.gov/show/NCT01462760
8429384293Efficacy and Safety Study of a Medical Device (KULIST)to Treat Perianal FistulasCompletedNo Results AvailablePerianal FistulasDevice: KULISThttps://ClinicalTrials.gov/show/NCT01462747
8429484294MicroRNA Expression in Human Blood Serum and Vitreous BodyCompletedNo Results AvailableMicroRNA Expression Profile in Human VitreousProcedure: human vitreous and blood serum sampling, PCRhttps://ClinicalTrials.gov/show/NCT01462734
8429584295The eSVS® Mesh Randomized Post-Market StudyTerminatedNo Results AvailableCoronary Artery Disease|Myocardial Ischemia|Coronary Disease|Heart Diseases|Cardiovascular Diseases|Arteriosclerosis|Arterial Occlusive Diseases|Vascular DiseasesDevice: eSVS® Meshhttps://ClinicalTrials.gov/show/NCT01462721
8429684296Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy SubjectsCompletedNo Results AvailableParkinson DiseaseDrug: [18F]MK-9470https://ClinicalTrials.gov/show/NCT01462708
8429784297Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaCompletedHas ResultsChildhood Cerebellar Anaplastic Astrocytoma|Childhood Cerebral Anaplastic Astrocytoma|Childhood Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent ChildOther: Diagnostic Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sunitinib Malatehttps://ClinicalTrials.gov/show/NCT01462695
8429884298Perception of Fatigue Among Surgeons During Night ShiftsCompletedNo Results AvailableFatiguehttps://ClinicalTrials.gov/show/NCT01462682
8429984299Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese SubjectsCompletedNo Results AvailableEpilepsyDrug: 50mg Ezogabine/retigabine|Drug: 100mg Ezogabine/retigabine|Drug: 200mg Ezogabine/retigabine|Drug: 400mg Ezogabine/retigabinehttps://ClinicalTrials.gov/show/NCT01462669
8430084300Risk of Urinary Retention With RetigabineActive, not recruitingNo Results AvailableEpilepsyDrug: Non-EZG containing AED polytherapy|Drug: EZG containing AED polytherapy|Drug: Non-EZG AED monotherapy|Drug: EZG AED monotherapyhttps://ClinicalTrials.gov/show/NCT01462656

* Görseller ve İçerik tekif hakkına sahip olabilir